ST elevation acute myocardial infarction accelerates non-culprit coronary lesion atherosclerosis

International Journal of Cardiovascular Imaging

Volumn 30, Issue 2, 2014, Pages 253-261

  Han, Yunfeng ^a   Jing, Jing ^a   Tu, Shengxian ^b   Tian, Feng ^a   Xue, Hao ^a   Chen, Weiren ^a   Chen, Jinsong ^a   Reiber, Johan H C ^b   Chen, Yundai ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Monocyte count; Non culprit coronary lesion; ST elevation acute myocardial infarction; Three dimensional quantitative coronary angiography

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ANGIOCARDIOGRAPHY; ANGIOGRAPHY DEVICE; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CELL COUNT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRINKING; FAMILY HISTORY; FASTING BLOOD GLUCOSE; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NON CULPRIT CORONARY LESION ATHEROSCLEROSIS; OBSERVATIONAL STUDY; PEAK MONOCYTE COUNT; PERCUTANEOUS CORONARY INTERVENTION; QUANTITATIVE ANALYSIS; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENOSIS DIAMETER; SYSTOLIC BLOOD PRESSURE; THREE DIMENSIONAL IMAGING;

AGED; CHI-SQUARE DISTRIBUTION; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY OCCLUSION; CORONARY STENOSIS; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899109502     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-013-0354-z     Document Type: Article

References (36)

1. Waters D, Craven TE, Lesperance J (1993) Prognostic significance of progression of coronary atherosclerosis. Circulation 87:1067-1075 (Pubitemid 23110377)
2. Kaski JC, Chester MR, Chen L, Katritsis D (1995) Rapid angiographic progression of coronary artery disease in patients with angina pectoris: The role of complex stenosis morphology. Circulation 92:2058-2065
3. Stone GW, Maehara A, Lansky AJ et al (2011) A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364:226-235
4. Kaski JC, Chen L, Chester M (1995) Rapid angiographic progression of "target" and "nontarget" stenoses in patients awaiting coronary angioplasty. J Am Coll Cardiol 26:416-421
5. Dutta P, Courties G, Wei Y et al (2012) Myocardial infarction accelerates atherosclerosis. Nature 487:325-329
6. Zouridakis E, Avanzas P, Arroyo-Espliguero R et al (2004) Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 110:1747-1753 (Pubitemid 39299216)
7. Tu S, Holm N, Koning G et al (2011) The impact of acquisition angle difference on three-dimensional quantitative coronary angiography. Catheter Cardiovasc Interv 78:214-222
8. Tu S, Xu L, Ligthart J et al (2012) In vivo comparison of arterial lumen dimensions assessed by co-registered three-dimensional (3D) quantitative coronary angiography, intravascular ultrasound and optical coherence tomography. Int J Cardiovasc Imag 28:1315-1327
9. Reiber JH, Serruys PW, Kooijman CJ et al (1985) Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 71:280-288 (Pubitemid 15157088)
10. Tuinenburg JC, Koning G, Rares A et al (2010) Dedicated bifurcation analysis: basic principles. Int J Cardiovasc Imag 26:169-174
11. Wallentin L, Lagerqvist B, Husted S et al (2000) Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomized trial. FRISC II investigators. Lancet 356:9-16 (Pubitemid 30416988)
12. Goldstein JA, Demetriou D, Grines CL et al (2000) Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343:915-922
13. Rioufol G, Finet G, Ginon I et al (2002) Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 106:804-808
14. Asakura M, Ueda Y, Yamaguchi O et al (2001) Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 37:1284-1288
15. Hong MK, Mintz GS, Lee CW et al (2004) Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 110:928-933 (Pubitemid 39136213)
16. Guazzi MD, Bussotti M, Grancini L et al (1997) Evidence of multifocal activity of coronary disease in patients with acute myocardial infarction. Circulation 96:1145-1151 (Pubitemid 27344216)
17. Brown BG, Zhao XQ, Chait A et al (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583-1592 (Pubitemid 33126837)
18. Reiber JHC, Tuinenburg JC, Koning G et al (2009) Quantitative coronary arteriography. In: Oudkerk M, Reiser MF (eds) Coronary radiology 2nd revised edition. Series: medical radiology. Baert AL, Knauth M, Sartor K (eds) Sub series: diagnostic imaging. Springer, Berlin, pp 41-65
19. Koning G, Hekking E, Kemppainen JS et al (2001) Suitability of the Cordis Stabilizer TM marker guide wire for quantitative coronary angiography calibration: an in vitro and in vivo study. Catheter Cardiovasc Interv 52:334-341 (Pubitemid 32184880)
20. Tu S, Huang Z, Koning G et al (2010) A novel three-dimensional quantitative coronary angiography system: in vivo comparison with intravascular ultrasound for assessing arterial segment length. Catheter Cardiovasc Interv 76:291-298
21. Olivares R, Ducimetiere P, Claude JR (1993) Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 137:49-53 (Pubitemid 23077307)
22. Chapman CM, Beilby JP, McQuillan BM et al (2004) Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 35:1619-1624 (Pubitemid 38823636)
23. Swirski FK, Pittet MJ, Kircher MF et al (2006) Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci USA 103:10340-10345 (Pubitemid 44051168)
24. Baigent C, Blackwell L, Emberson J et al (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376:1670-1681
25. Nissen SE, Tuzcu EM, Schoenhagen P et al (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291:1071-1080 (Pubitemid 38541684)
26. Nicholls SJ, Ballantyne CM, Barter PJ et al (2011) Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med 365:2078-2087
27. Bayturan O, Kapadia S, Nicholls SJ et al (2010) Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol. J Am Coll Cardiol 55:2736-2742
28. Gordon T, Castelli WP, Hjortland MC et al (1977) High density lipoprotein as a protective factor against coronary heart disease: the Framingham study. Am J Med 62:707-714 (Pubitemid 8110784)
29. Barter P, Gotto AM, LaRosa JC et al (2007) HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357:1301-1310 (Pubitemid 47481452)
30. Nicholls SJ, Cutri B, Worthley SG et al (2005) Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 25:2416-2421 (Pubitemid 41552664)
31. Rong JX, Li J, Reis ED et al (2001) Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation 104:2447-2452 (Pubitemid 33108379)
32. Shah PK, Yano J, Reyes O et al (2001) High-dose recombinant apolipoprotein A-IMilano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein E-deficient mice. Circulation 103:3047-3050 (Pubitemid 32587849)
33. Cui Y, Watson DJ, Girman CJ et al (2009) Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). Am J Cardiol 104:829-834
34. Kolodgie FD, Gold HK, Burke AP et al (2003) Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349:2316-2325 (Pubitemid 37509739)
35. Takaya N, Yuan C, Chu B et al (2005) Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 111:2768-2775 (Pubitemid 40791548)
36. Kaski JC, Chester MR, Chen L, Katritsis D (1995) Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation 92:2058-2065